NeuroMetrix, Inc. , a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico.
Neurometrix stock last closed at $4.36, up 0% from the previous day, and has decreased 7.23% in one year. It has overperformed other stocks in the Medical Devices industry by 0.07 percentage points. Neurometrix stock is currently +63.91% from its 52-week low of $2.66, and -7.82% from its 52-week high of $4.73.
There are currently 2.06M shares of NURO outstanding. The market capitalization of NURO is $8.98M. In the past 24 hours, 20,834 NURO shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy NURO shares.
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you'll need to fill out some personal information so you are able to invest in NURO stock today.
Now that you've created your account on the best stock app to use, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your investment account.
After you have chosen the best place to buy Neurometrix stock, it's important to analyze their stock before you buy, so you truly understand the risk and upside.
WallStreetZen was built to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on NURO's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge NURO's fair value.
Using relative valuations metrics:
You can access additional valuation research on NURO's stock here.
Last year, NURO revenue was $3.03M. During the last five year, NURO's revenue has grown by -20.03% per year. This was slower than the Medical Devices industry average of 9.91%.
Dig into NURO's earnings and revenue performance here.
Over the past year, insiders at NURO have bought more shares than they have sold.
Shai Gozani, Director of NURO, was the latest NURO insider to buy. They bought $2,756.25 worth of NURO shares on Apr 1, 2025.
Research more about who owns NURO stock here.
No, Neurometrix doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two main types of orders:
Click the Open Trade button and your broker will execute your order.
If you require more help with investing in stocks on eToro, watch the helpful video below:
Now that you own some NURO shares, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to get the latest updates about your NURO stock.
To summarize, here are the 6 steps to buy stock in Neurometrix:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Neurometrix, create your watchlist below.